IRadimed (IRMD) Financials: Revenue & Earnings

IRMD price $83.97 +0.02 +0.03%

Ticker
IRMD
Price
$83.97
Change
+0.02 +0.03%
Market cap ?
$1.07B
P/E ?
47.15
Forward P/E ?
39.74
Dividend yield ?
1.48%
Beta ?
0.91
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
53
Value
21
Quality
87
Growth
51

Stocklytics score rationale: value 21, quality 87, growth 51.

Financials

2016201720182019202020212022202320242025
32496548230815923043898338517141317173724181458153303145655622967324212183814000

IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump…

Fair value

IRMD fair value $73.35. Price $83.97. Price is 14% above fair value.

Above fair value, and more expensive than usual. A larger premium than on 81% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 24.93M. Growth 9.93%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.32% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 12.79M. Net debt -51.16M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare IRMD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-30—0.55—23.47M
2026-07-310.460.4420.47M20.35M
2026-05-010.490.4521.98M21.32M
2026-02-100.540.4922.69M21.60M
2025-11-030.470.4821.20M21.60M
2025-08-010.490.4520.41M20.50M
2025-05-050.420.4319.51M19.33M
2025-02-130.440.4519.39M19.20M
2024-10-310.430.3918.33M18.94M
2024-08-010.420.3717.93M17.65M
2024-05-020.360.3417.60M17.13M
2024-02-080.390.4017.45M17.33M
2023-11-030.430.3616.50M16.17M
2023-08-030.360.3116.13M15.65M
2023-05-040.300.2815.48M14.77M
2023-02-020.320.3014.86M14.90M
2022-11-030.290.2513.41M13.19M
2022-07-290.260.2412.72M12.60M
2022-04-290.220.2112.31M12.21M
2022-02-040.330.2111.87M11.65M
2021-10-290.230.1710.91M10.40M
2021-07-300.140.109.81M9.81M
2021-04-300.130.109.22M6.46M
2021-02-040.070.098.55M11.65M
2020-10-300.110.107.70M7.00M
2020-07-300.050.006.79M—
2020-04-300.180.158.68M7.23M
2020-02-060.300.2110.89M7.62M
2019-10-300.230.169.96M6.93M
2019-07-300.200.159.23M6.92M
2019-04-300.130.158.44M9.74M
2019-02-060.160.138.34M6.78M
2018-10-300.140.107.61M5.44M
2018-07-310.140.107.38M5.27M
2018-04-300.100.067.11M5.86M
2018-02-060.100.056.70M5.53M
2017-10-300.070.035.69M4.69M
2017-07-280.060.015.52M920.00K
2017-04-28-0.02-0.015.16M18.59M
2017-02-060.110.045.99M2.18M

Dividends

Yield 1.51%. Payout ratio 68.66%. Frequency Quarterly.

Safety score 75/100 · Safe. Payout ratio is 69% of earnings. Dividends use a moderate share of free cash flow. Dividends were paid in 5 separate years. Yield is 1.5%, in a range that is usually sustainable.

Ex-dateDividendRecordPaymentFrequency
2026-08-14$0.202026-08-142026-08-28Quarterly
2026-05-15$0.202026-05-152026-05-29Quarterly
2026-02-23$0.202026-02-232026-03-06Quarterly
2025-12-17$0.502025-12-172025-12-30Special
2025-11-14$0.172025-11-142025-11-25Quarterly
2025-08-18$0.172025-08-182025-08-28Quarterly
2025-05-20$0.172025-05-202025-05-30Quarterly
2025-02-24$0.172025-02-242025-03-05Quarterly
2024-11-15$0.152024-11-152024-11-25Quarterly
2024-08-20$0.152024-08-202024-08-30Quarterly
2024-05-17$0.152024-05-202024-05-30Quarterly
2023-12-21$0.632023-12-222024-01-12Special
2023-02-10$1.052023-02-132023-02-21Special
2022-02-16$1.002022-02-172022-02-24Special

Insider trades

DateInsiderActionSharesPriceValue
2026-09-23KIANI JOE ESell698——
2026-09-23KIANI JOE EBuy698——
2026-09-03ALLEN MONTY KSell1.01K$86.4487.65K
2026-09-03ALLEN MONTY KSell405$86.3534.97K
2026-06-20GLENN JOHNBuy5.80K——
2026-06-20GLENN JOHNSell2.32K$92.20213.81K
2026-06-20GLENN JOHNSell5.80K——
2026-06-04Scharen-Guivel Hilda FrederiqueSell1.77K$95.00167.77K
2026-06-04Scharen-Guivel Hilda FrederiqueSell1.23K$95.00117.23K
2026-06-01Susi Roger E.Sell400$88.6835.47K
2026-06-01Susi Roger E.Sell775$89.7969.59K
2026-06-01Susi Roger E.Sell401$91.0836.52K
2026-06-01Susi Roger E.Sell924$91.9184.92K
2026-05-27Susi Roger E.Sell2.17K$91.85199.04K
2026-05-27Susi Roger E.Sell333$92.6130.84K
2026-05-26Susi Roger E.Sell3.11K$91.81285.62K
2026-05-26Susi Roger E.Sell1.89K$92.93175.54K
2026-05-19Susi Roger E.Sell653$87.1356.90K
2026-05-19Susi Roger E.Sell1.84K$88.14162.27K
2026-05-19Susi Roger E.Sell6$88.65532
2026-05-18Susi Roger E.Sell298$85.9525.61K
2026-05-18Susi Roger E.Sell3.45K$87.35301.44K
2026-05-18Susi Roger E.Sell1.25K$88.34110.51K
2026-05-12Susi Roger E.Sell3.31K$83.70276.80K
2026-05-12Susi Roger E.Sell1.10K$84.5993.39K
2026-05-11Susi Roger E.Sell1.77K$84.08149.07K
2026-05-11Susi Roger E.Sell1.00K$84.9485.02K
2026-05-11Susi Roger E.Sell315$85.9027.06K
2026-05-05Susi Roger E.Sell600$83.7850.27K
2026-05-05Susi Roger E.Sell1.32K$85.56113.11K
2026-05-05Susi Roger E.Sell1.65K$86.43142.61K
2026-05-05Susi Roger E.Sell178$87.3115.54K
2026-05-04Susi Roger E.Sell2.45K$85.32208.78K
2026-05-04Susi Roger E.Sell1.10K$86.2695.14K
2026-05-04Susi Roger E.Sell200$87.0517.41K
2026-04-28Susi Roger E.Sell998$84.1383.96K
2026-04-28Susi Roger E.Sell847$85.7772.65K
2026-04-28Susi Roger E.Sell742$86.5264.20K
2026-04-28Susi Roger E.Sell900$88.0079.20K
2026-04-28Susi Roger E.Sell263$88.8123.36K
2026-04-27Susi Roger E.Sell2.82K$88.98250.83K
2026-04-27Susi Roger E.Sell931$89.7083.51K
2026-04-21Susi Roger E.Sell1.16K$89.73104.27K
2026-04-21Susi Roger E.Sell140$90.6012.68K
2026-04-21Susi Roger E.Sell606$91.6555.54K
2026-04-21Susi Roger E.Sell592$92.6654.85K
2026-04-20Susi Roger E.Sell3.58K$93.14333.44K
2026-04-20Susi Roger E.Sell1.42K$93.90133.34K
2026-04-14Susi Roger E.Sell2.11K$93.71197.45K
2026-04-14Susi Roger E.Sell393$94.5537.16K
2026-04-13Susi Roger E.Sell1.85K$91.84169.63K
2026-04-13Susi Roger E.Sell2.56K$92.79237.91K
2026-04-13Susi Roger E.Sell589$93.4555.04K
2026-04-07Susi Roger E.Sell1.52K$94.36143.24K
2026-04-07Susi Roger E.Sell982$95.5893.86K
2026-04-06Susi Roger E.Sell1.36K$95.21129.20K
2026-04-06Susi Roger E.Sell3.07K$96.24295.84K
2026-04-06Susi Roger E.Sell569$96.7855.07K
2026-03-30Susi Roger E.Sell5.85K$94.81554.45K
2026-03-30Susi Roger E.Sell1.50K$95.66143.20K
2026-03-30Susi Roger E.Sell155$96.5314.96K
2026-03-24Susi Roger E.Sell1.58K$100.03158.55K
2026-03-24Susi Roger E.Sell915$100.7192.15K
2026-03-23Susi Roger E.Sell2.95K$99.58293.76K
2026-03-23Susi Roger E.Sell750$100.7075.53K
2026-03-23Susi Roger E.Sell1.30K$102.02132.63K
2026-03-17Susi Roger E.Sell2.50K$102.43256.08K
2026-03-16Susi Roger E.Sell3.01K$101.18304.45K
2026-03-16Susi Roger E.Sell1.99K$101.68202.44K
2026-03-10Susi Roger E.Sell2.50K$100.11250.28K
2026-03-09Susi Roger E.Sell5.00K$100.04500.20K
2026-03-06Susi Roger E.Sell6.30K$98.25618.98K
2026-03-06Susi Roger E.Sell1.20K$99.12118.94K
2026-03-03Chiprin JeffBuy1.15K——
2026-03-03GLENN JOHNBuy8.91K——
2026-02-13ALLEN MONTY KSell1.00K$100.26100.26K
2026-01-26Susi Roger E.Sell4.34K$100.54436.24K
2026-01-26Susi Roger E.Sell661$101.3867.01K
2026-01-20Susi Roger E.Sell2.13K$101.03215.09K
2026-01-20Susi Roger E.Sell1.07K$102.03109.58K
2026-01-20Susi Roger E.Sell1.80K$102.70184.55K
2026-01-12Susi Roger E.Sell4.89K$97.43476.24K
2026-01-12Susi Roger E.Sell112$98.1510.99K
2026-01-05Susi Roger E.Sell854$95.1081.22K
2026-01-05Susi Roger E.Sell300$95.5828.67K
2026-01-05Susi Roger E.Sell883$97.5286.11K
2026-01-05Susi Roger E.Sell2.21K$98.42217.41K
2026-01-05Susi Roger E.Sell754$99.4875.01K
2025-12-29Susi Roger E.Sell4.90K$97.65478.39K
2025-12-29Susi Roger E.Sell101$98.319.93K
2025-12-22Susi Roger E.Sell3.77K$96.42363.70K
2025-12-22Susi Roger E.Sell1.23K$97.70119.98K
2025-12-15Susi Roger E.Sell4.27K$96.68412.73K
2025-12-15Susi Roger E.Sell731$97.1371.00K
2025-12-11Scharen-Guivel Hilda FrederiqueBuy1.03K——
2025-12-11HAWKINS JAMES BBuy1.03K——
2025-12-11ALLEN MONTY KBuy1.03K——
2025-12-11Chiprin JeffSell996——
2025-12-11Chiprin JeffBuy996——
2025-12-11Chiprin JeffSell309$97.3830.09K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 218, holders -14 vs prior quarter. Ownership 61.96%.

HolderSharesChangeChange %Value
BLACKROCK, INC.967.83K38+0.00%92.49M
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC396.98K47.67K+13.65%37.94M
RENAISSANCE TECHNOLOGIES LLC394.41K-46.30K-10.51%37.69M
COPELAND CAPITAL MANAGEMENT, LLC391.86K32.53K+9.05%37.45M
VANGUARD CAPITAL MANAGEMENT LLC364.94K6.32K+1.76%34.87M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.318.68K61.98K+24.15%30.45M
GEODE CAPITAL MANAGEMENT, LLC290.11K3.55K+1.24%27.73M
NINE TEN CAPITAL MANAGEMENT LLC256.56K-77.93K-23.30%24.52M
DIMENSIONAL FUND ADVISORS LP229.34K3.19K+1.41%21.91M
STATE STREET CORP221.51K16.98K+8.30%21.17M
GOLDMAN SACHS GROUP INC214.15K16.21K+8.19%20.46M
TWO SIGMA INVESTMENTS, LP182.89K17.23K+10.40%17.48M
QUBE RESEARCH & TECHNOLOGIES LTD157.20K73.75K+88.38%15.02M
ROYAL BANK OF CANADA148.18K118.37K+397.11%14.16M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP143.97K128.52K+832.14%13.76M
NORTHERN TRUST CORP133.66K10.02K+8.11%12.77M
ACADIAN ASSET MANAGEMENT LLC128.66K-23.18K-15.27%12.29M
MORGAN STANLEY126.05K-23.79K-15.88%12.05M
VANGUARD PORTFOLIO MANAGEMENT LLC125.36K2.93K+2.39%11.98M
RANGER INVESTMENT MANAGEMENT, L.P.98.35K-12.74K-11.47%9.40M
RUSSELL INVESTMENTS GROUP, LTD.94.98K-4.52K-4.54%9.08M
FIRST TRUST ADVISORS LP84.32K84.32KNew8.06M
SHAKER INVESTMENTS LLC/OH81.64K21.60K+35.98%7.80M
ENVESTNET ASSET MANAGEMENT INC78.56K3.10K+4.11%7.51M
BANK OF NEW YORK MELLON CORP75.89K-3.99K-5.00%7.25M

Earnings and financials

IRadimed Corporation (IRMD) trades at $83.97, with a market cap of $1.07B and a trailing P/E of 47.15. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
32496548230815923043898338517141317173724181458153303145655622967324212183814000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

IRadimed (IRMD) Financials: Revenue & Earnings

IRMD$83.97+0.02 +0.03%

$1.07B

Market Cap

47.15

P/E

39.74

Forward P/E

53

Score

Price History